Submitted to the United Nation's Committee on the Convention on the Elimination
of All Forms of Discrimination Against Women
February 2016
Published by the Albanian Center for Population and Development (ACPD) Adresa : Bul “ Gjergj Fishta”, Kompleksi “Tirana 2000” Kulla 4, kati 2, Tir...anë Web: www.acpd.al.org
more
Country Progress Report
Reporting Period
January – December, 2014
Accessed: 26.09.2019
Evaluation report
September 2014
Promising Approaches to Combination HIV Prevention Programming in Concentrated Epidemics
AIDSTAR-One CASE STUDY SERIES May 2010
1-13 December 2018 | Geneva, Switzerland UNAIDS Programme Coordinating Board Issue date: 23 November 2018
UNAIDS/PCB (43)/18.32
Case Study on Improving HIV Testing and Services for Children Orphaned or made Vulnerable by HIV (OVC)
Minimum standards of home care for older people in Red Cross Red Crescent volunteer-based programming in the Europe Zone
Child Survival Working Group
Accessed: 30.10.2019
Global AIDS Update 2018
Closing Gaps
Breaking Barriers
Righting injustices
UNAIDS/10.03E / JC1767E (English original, March 2010) ISBN 978 92 9 173849 6
Technical Brief
HIV patient monitoring and case surveillance
WHO/HIV/2017.12
Vision 2030
Accessed: 17.11.2019
Advocacy achievements of the bridging the gaps global partners
Accessed: 17.11.2019
UNAIDS 2018 / Guidance
Guidance for policy-makers, and people living with, at risk of or affected by HIV
It's time to deliver differently.
Accessed: 13.11.2019
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the population. To fulfill its mandate, DPMED aims to stre...ngthen its regulatory capacity, including the issuance of licenses to pharmaceutical establishments and the registration of pharmaceutical products. Benin’s current registration system shares core concerns that are common to most developing countries, notably the capacity to evaluate and monitor the security, efficacy, and quality of medicines and other health products. It is currently characterized by 1) poor or inadequate traceability of records or regulations (example: a product’s marketing authorization [MA] is often hard to find); 2) lack of evidence used in the regulatory decision-making process (reasons behind special import authorization, i.e., products without valid MAs); 3) inconsistent and unsecured archiving system; 4) limited human resources; and 5) an inefficient information management system
more